Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Pelvic Neoplasm”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Not applicableStudy completedNCT00166361
What this trial is testing

Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent

Who this might be right for
Ureteral Obstruction
Mayo Clinic 29
Not applicableStudy completedNCT04184154
What this trial is testing

Sexual Quality of Life of Patients With Gynecologic Cancer Treated With Brachytherapy.

Who this might be right for
Pelvic CancerCervical Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 167
Not applicableLooking for participantsNCT05696002
What this trial is testing

Advanced Pelvic Surgical Oncology Database - Prospective Observational Study

Who this might be right for
Rectal CancerPelvic CancerGynecologic Cancer+1 more
Glasgow Royal Infirmary 300
Early research (Phase 1)Study completedNCT02300610
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
H. Lee Moffitt Cancer Center and Research Institute 10
Large-scale testing (Phase 3)Study completedNCT00647569
What this trial is testing

Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer

Who this might be right for
Incisional HerniaPelvic Cancer
University of Aarhus 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT04953104
What this trial is testing

ARID1A and/or KDM6A Mutation and CXCL13 Expression

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+29 more
M.D. Anderson Cancer Center 6
Post-approval studies (Phase 4)Study completedNCT01946672
What this trial is testing

Lower-Limb Drainage Mapping in Pelvic Lymphadenectomy for Gynaecological Cancer

Who this might be right for
Gynaecological Malignant Tumours With Indication of Pelvic Lymphadenectomy
Assistance Publique - Hôpitaux de Paris 44
Early research (Phase 1)Looking for participantsNCT05614739
What this trial is testing

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company 535
Not applicableActive Not RecruitingNCT04713618
What this trial is testing

Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

Who this might be right for
Anal CarcinomaCervical CarcinomaEndometrial Carcinoma+4 more
Ohio State University Comprehensive Cancer Center 72
Not applicableStudy completedNCT04344899
What this trial is testing

Pediatric Oncology Recovery Trial After Surgery

Who this might be right for
Pelvic Cancer
University of Colorado, Denver 74
Not applicableStudy completedNCT04008537
What this trial is testing

Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device

Who this might be right for
Cancer of PancreasCancer of PelvisCancer of Abdomen+1 more
Washington University School of Medicine 37
Not applicableLooking for participantsNCT06185062
What this trial is testing

Pelvic Cancer Registry for Online Adapted Radiotherapy

Who this might be right for
Pelvic TumorThoracic Tumor
University Medical Center Goettingen 846
Early research (Phase 1)Active Not RecruitingNCT04620603
What this trial is testing

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

Who this might be right for
Cutaneous Malignant MelanomaRenal Cell CancerUrothelial Cancer of Renal Pelvis
Case Comprehensive Cancer Center 5
Not applicableActive Not RecruitingNCT03739775
What this trial is testing

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

Who this might be right for
HPV Positive Pelvic Cancer
Institut Curie 172
Not applicableLooking for participantsNCT05219058
What this trial is testing

Reconstruction in Extended MArgin Cancer Surgery

Who this might be right for
Surgery--ComplicationsPelvic CancerAbdominal Cancer+1 more
University Hospital Southampton NHS Foundation Trust 236
Testing effectiveness (Phase 2)Study completedNCT03757858
What this trial is testing

Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases

Who this might be right for
CancerAbdominal CancerPelvic Cancer+3 more
Capital Medical University 40
Not applicableActive Not RecruitingNCT06187103
What this trial is testing

Evaluation of Improved Onboard Patient Imaging

Who this might be right for
Head and Neck CancerBreast CancerUpper Gastrointestinal Cancer+2 more
Varian, a Siemens Healthineers Company 40
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT00942331
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

Who this might be right for
Advanced Urothelial CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Prostate Carcinoma+10 more
National Cancer Institute (NCI) 506
Large-scale testing (Phase 3)Study completedNCT00949039
What this trial is testing

Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer

Who this might be right for
Gynaecologic or Digestive Pelvic Cancer
Gustave Roussy, Cancer Campus, Grand Paris 101
Load More Results